Use of cell-permeable peptides to prevent neuronal degeneration

Tiziana Borsello1, Christophe Bonny

  • 1IBCM, University of Lausanne, Lausanne, Switzerland. Tiziana.Borsello@ibcm.unil.ch

Insights

Targeting protein interactions with specific peptides can block cell death pathways in neurodegenerative disorders. A peptide inhibiting c-Jun N-terminal kinase shows promise for treating neuronal loss after ischemia.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Neuronal loss is a key feature of neurodegenerative diseases, often involving apoptosis.
  • Signal transduction pathways activated by cellular insults lead to neuronal death and disease pathology.
  • Protein kinases play a crucial role in mediating cell-death signaling cascades.

Purpose of the Study:

  • To review recent findings on therapeutic strategies targeting protein interactions in neurodegenerative disorders.
  • To highlight the potential of peptide inhibitors in blocking key signaling mediators.
  • To discuss the application of inhibiting c-Jun N-terminal kinase for neuronal protection.

Main Methods:

  • Review of recent scientific literature on neurodegeneration and apoptosis.
  • Analysis of signaling pathways involving protein kinases and their substrates.
  • Evaluation of studies using cell-permeable peptides to inhibit specific protein interactions, particularly c-Jun N-terminal kinase.

Main Results:

  • Blocking protein-protein interactions offers an alternative to targeting substrate phosphorylation in cell-death pathways.
  • A cell-permeable peptide inhibitor of c-Jun N-terminal kinase demonstrated efficacy in preclinical models.
  • This approach showed success in preventing neuronal degeneration following ischemic events.

Conclusions:

  • Interfering with specific protein interactions, such as those involving c-Jun N-terminal kinase, presents a promising therapeutic avenue.
  • Peptide-based inhibitors can effectively block critical signaling cascades implicated in neuronal death.
  • This strategy holds significant potential for developing novel treatments for neurodegenerative conditions and stroke.